Summary
  • Multi-target molecules 315
  • Clinical molecules 0
  • Avg pChEMBL 7.76
Top Co-occurrence Targets
Active Molecules (315)
InChIKey pChEMBL Type Targets Clinical
HFHFKADRFFQQFW 8.2 IC50 3
SFPFFBUIHDKPII 8.2 IC50 4
JPGZCAXFIKAHMN 8.2 IC50 3
BINCDYYXLHADFN 8.2 IC50 4
CKAFLNNMQJGEEX 8.2 IC50 4
PXWLCVOXAJCIHF 8.2 IC50 4
BBYREDGIRGSUDH 8.2 IC50 3
GCEYGBNIYJGZTN 8.2 IC50 4
LOKNAZXSPVVJPF 8.2 IC50 4
MVZJTRIKXSAMAF 8.2 IC50 4
SZDWNVOCTLNFPG 8.2 IC50 4
XNEUYKAPFWMJHA 8.2 IC50 4
DOEZXCZJNCFNGG 8.1 IC50 3
GWTCJMHDXSFEIJ 8.1 Ki 3
BHALPSWCUUSMHK 8.1 IC50 4
DAXDBSLQHVZVKM 8.1 IC50 4
DJJPDGXKHXSURY 8.1 IC50 4
GCEYGBNIYJGZTN 8.1 IC50 4
GRLUHAWWANYLEN 8.1 IC50 4
JOSLQAAOZQRHRW 8.1 IC50 4
RDKJPYDNPLIEFF 8.1 IC50 4
RKPNCHNEDXAJST 8.1 IC50 4
ULLHRUAXAUBKJJ 8.1 IC50 4
VWXNOLOTOLRZRB 8.1 IC50 4
WCCYJARGTVUAAM 8.1 IC50 4
XICAUTQYHONJLM 8.1 Ki 2
XSKKSWVGQBWSOZ 8.1 IC50 4
CUSGUKNSSJKVAE 8.1 IC50 4
GZMVTKDVGHBZSO 8.1 IC50 4
MITIRLDOBCLPIX 8.0 IC50 3
DAXDBSLQHVZVKM 8.0 IC50 4
HIAOHWNJALUKDL 8.0 Ki 2
IVDACYIUQQEBBQ 8.0 Ki 2
JYCRVNJJDICZRJ 8.0 IC50 4
MGSVVADKJYNHMZ 8.0 Ki 2
MSAOFHITMMVUMV 8.0 IC50 4
PWGWJCARSBIEBH 8.0 IC50 4
RDHZGKIYONRFGL 8.0 IC50 4
SIORZSNWZVSXNL 8.0 Ki 3
VNMXHBWOMGLDIH 8.0 IC50 4
WGQPESPJQGRZGU 8.0 IC50 4
XGYPBUXSGXUJCL 8.0 Ki 2
XPKDLKMXYDYWGP 8.0 IC50 4
FSVNUGQYUJXOOG 8.0 IC50 4
LFKITAOQQDIAJF 8.0 Ki 2
BHWFBUYKOSMKDR 7.9 Ki 2
OKVITQHRBJKNTP 7.9 Ki 2
GOTBKWCJQKETSF 7.8 Ki 2
CFINSCMSFLQQAR 7.8 IC50 4
CMRUZHOEIPFESP 7.8 IC50 4
2D structure